(Q51500055)

English

Effects of metformin on the glycemic control, lipid profile, and arterial blood pressure of type 2 diabetic patients with metabolic syndrome already on insulin.

scientific article published on 3 April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16612472

Effects of metformin on the glycemic control, lipid profile, and arterial blood pressure of type 2 diabetic patients with metabolic syndrome already on insulin. (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16612472

metabolic syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

C A Mourão-Júnior

1

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16612472

J R Sá

2

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16612472

O M S Guedes

3

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16612472

S A Dib

4

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16612472

language of work or name

0 references

publication date

3 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16612472

Brazilian Journal of Medical and Biological Research

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16612472

39

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16612472

4

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16612472

489-494

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16612472

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Insulin-metformin combination therapy in obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Combination of insulin and metformin in the treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Metformin: An Update

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes.

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors.

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Hypertension and the cardiometabolic syndrome

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Abdominal obesity and expression of familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Using new insulin strategies in the outpatient treatment of diabetes: clinical applications

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Do effects on blood pressure contribute to improved clinical outcomes with metformin?

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2006000400009

21 January 2018

Identifiers

10.1590/S0100-879X2006000400009

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16612472

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16612472

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51500055&oldid=1364706314"